ARCHIVES

ODAC Reviews Post-Marketing Studies for Eight Indications

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

NCI To Support 39 Summer Students With Gift Money

February 8, 1985

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

March 21, 1986

Black Teens At Higher Risk Of Tobacco Addiction.

February 2, 2001

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

New RFAs on Retinoids & Carotenoids, Tobacco, NMR Research Resistance

July 27, 1984